Michael B. Mason - 09 Feb 2022 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role: Sr. VP & Pres., Lilly Diabetes
Signature: /s/ Jonathan Groff for Michael B. Mason, pursuant to attached authorization
Issuer symbol: LLY
Transactions as of: 09 Feb 2022
Net transactions value: +$635,421
Form type: 4
Filing time: 11 Feb 2022, 17:19:22 UTC
Next filing: 03 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LLY	Common Stock	Award	$635,421	+2,612	+10%	$243.27	27,506	09 Feb 2022	Direct
holding	LLY	Common Stock						935	09 Feb 2022	401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LLY	Restricted Stock Unit	Award	$0	+6,690		$0.000000	6,690	09 Feb 2022	Common Stock	6,690		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.